New York Life Investment Management LLC Acquires 620,113 Shares of Axon Enterprise, Inc $AXON

New York Life Investment Management LLC increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 4,560.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 633,710 shares of the biotechnology company’s stock after acquiring an additional 620,113 shares during the quarter. Axon Enterprise makes up about 1.8% of New York Life Investment Management LLC’s holdings, making the stock its 9th biggest position. New York Life Investment Management LLC owned 0.78% of Axon Enterprise worth $267,755,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of AXON. M & L Capital Management Ltd purchased a new position in Axon Enterprise during the 3rd quarter worth $30,000. Keating Financial Advisory Services Inc. acquired a new position in Axon Enterprise in the second quarter valued at $31,000. Wealth Enhancement Trust Services Inc. purchased a new stake in shares of Axon Enterprise in the third quarter valued at about $33,000. Putney Financial Group LLC purchased a new stake in shares of Axon Enterprise in the third quarter valued at about $36,000. Finally, Washington Trust Advisors Inc. raised its holdings in shares of Axon Enterprise by 1,300.0% in the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after buying an additional 65 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

AXON has been the subject of several recent research reports. The Goldman Sachs Group decreased their target price on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a research note on Monday, September 21st. Argus boosted their price target on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. Morgan Stanley upped their price objective on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Northcoast Research increased their price objective on Axon Enterprise from $650.00 to $680.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Finally, Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $612.18.

Insiders Place Their Bets

In other news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the transaction, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This represents a 0.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the company’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the transaction, the insider directly owned 56,264 shares in the company, valued at approximately $27,032,038.80. This trade represents a 1.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 37,397 shares of company stock worth $21,234,034 in the last ninety days. 4.20% of the stock is owned by insiders.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will become its U.S. public-safety distributor. The deal could broaden Axon’s public-safety technology offering, though its scale also brings investment and execution risks. Axon invests in Skydio
• Positive Sentiment: West Fargo police plan to replace Flock technology with Axon’s system, including new AI features—an example of continued adoption by public-safety customers. West Fargo police adoption
• Positive Sentiment: Despite lowering its price target, Barclays retained an “overweight” rating at $507; Northland reportedly still sees a $540 target after the stock’s steep fall from its August high. These views suggest some analysts see substantial recovery potential, though targets are not guarantees. Northland target outlook
• Neutral Sentiment: A short-interest report lists 0 shares short, despite describing a large increase. The figure appears inconsistent and does not provide a reliable indication of short-selling pressure.
• Negative Sentiment: Axon’s third-quarter adjusted EPS of $1.72 and revenue of about $909 million fell short of estimates. Cautious guidance and roughly $130 million in federal-contract revenue shifting out of 2026 have weighed on the outlook; shares have fallen sharply since the results, while Motorola rose after its earnings beat. Axon versus Motorola after earnings
• Negative Sentiment: Law firms announced investigations into potential securities-law violations. These are allegations under investigation, not findings of wrongdoing, but may add legal and reputational uncertainty for investors. Axon securities investigation notice

Axon Enterprise Stock Down 0.2%

AXON opened at $302.54 on Wednesday. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. Axon Enterprise, Inc has a 12 month low of $291.45 and a 12 month high of $665.07. The stock has a market capitalization of $24.58 billion, a P/E ratio of 96.97, a P/E/G ratio of 5.76 and a beta of 1.48. The business has a 50 day simple moving average of $430.30 and a 200-day simple moving average of $472.14.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The business had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. During the same period in the prior year, the company earned $1.17 EPS. The company’s revenue was up 27.8% on a year-over-year basis. On average, equities analysts anticipate that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.